A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings, published in Nature Cancer, may help improve future ways to deliver this cellular immunotherapy for…
Category: 5. Health
-
Engineering an antibody against flu with sticky staying power
Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the broad binding capacity of a more general immune system defender.
The protective effect was…
Continue Reading
-
AI-designed DNA controls genes in healthy mammalian cells for first time
A study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. Researchers at the Centre for Genomic Regulation (CRG) created an AI tool which dreams up DNA…
Continue Reading
-
Vitamin supplements slow down the progression of glaucoma
A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. Promising results have been published in the journal Cell Reports Medicine. The researchers behind the study have now started a clinical trial on patients.
In glaucoma, the optic…
Continue Reading
-
Building vaccines for future versions of a virus
Effective vaccines dramatically changed the course of the COVID-19 pandemic, preventing illness, reducing disease severity, and saving millions of lives.
However, five years later, SARS-CoV-2 is still circulating, and in the process, evolving into new variants that require updated vaccines to…
Continue Reading
-
Incidence of several early-onset cancers increased between 2010 and 2019
In the United States, breast, colorectal, endometrial, pancreatic, and kidney cancers are becoming increasingly common among people under age 50, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research (AACR).
The findings may have…
Continue Reading
-
$1.8 billion in NIH grant cuts hit minority health research the hardest
The headlines keep coming: Another federal grant funding medical research terminated. Another lab devoted to mental health losing its funding. Another clinical trial stopped.
It’s all part of actions the Trump administration says are needed to make government more efficient or to…
Continue Reading
-
Novel Antivenom ‘Cocktail’ Neutralizes Venomous Snake Bites
Venom from snakes and other animals can have fatal effects if not treated. Venom is a toxic substance and includes various components, including neurotoxins. Consequently, the neurotoxins within the venom disrupt the nervous system and cause deleterious…
Continue Reading
-
Genetic Code Regulates Stress Response in Cells
Each cell has their own genetic code that helps maintain viability and directs function. This genetic code is commonly referred to as deoxyribonucleic acid or DNA. DNA is the molecule that carries genetic instructions that dictate the development and…
Continue Reading
-
Teens who want to quit vaping have another medication option
Many teens who vape want to quit. A recent clinical trial suggests that a drug used to stop smoking can help.
In the last four weeks of a 12-week trial, 51 percent of the 88 teens and young adults taking the drug varenicline, which was paired with counseling and text messaging…
Continue Reading